10 studies found for:    lixisenatide | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Lixisenatide (AVE0010);   Drug: Placebo;   Drug: Basal Insulin;   Drug: Metformin
2 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010);   Drug: Lixisenatide (AVE0010);   Drug: Oral anti-diabetic drugs
3 Recruiting Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
Conditions: Diabetes Mellitus;   Gastroparesis
Interventions: Drug: Lixisenatide;   Drug: Placebo
4 Not yet recruiting Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Lixisenatide;   Drug: Basal insulins
5 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: insulin glargine/lixisenatide fixed ratio combination;   Drug: liraglutide;   Drug: exenatide;   Drug: exenatide extended-release;   Drug: albiglutide;   Drug: dulaglutide;   Drug: metformin;   Drug: pioglitazone
6 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/lixisenatide (HOE901/AVE0010);   Drug: Insulin glargine (HOE901);   Drug: Oral anti-diabetic drugs
7 Recruiting Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010);   Drug: Insulin glargine U100 (HOE901);   Drug: Metformin
8 Recruiting Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
Condition: Diabetes Mellitus
Interventions: Drug: Lixisenatide;   Other: Placebo
9 Recruiting The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Liraglutide;   Drug: metformin
10 Recruiting Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
Conditions: Type 2 Diabetes;   Incretinomimetics;   Pancreas
Interventions: Drug: Incretinomimetics;   Drug: DPP-4 inhibitors

Indicates status has not been verified in more than two years